Pure Global

THE EFFICACY OF MOISTURIZERS IN RESTORING HYDRATION,SKIN pH, AND REDUCING TRANS-EPIDERMAL WATER LOSS(TEWL) IN PATIENTS WITH ATOPIC DERMATITIS - Trial PACTR202209711529835

Access comprehensive clinical trial information for PACTR202209711529835 through Pure Global AI's free database. This Phase 2 trial is sponsored by University of Lagos and is currently Recruiting. The study focuses on Skin and Connective Tissue Diseases.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR202209711529835
Phase 2
Recruiting
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR202209711529835
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
THE EFFICACY OF MOISTURIZERS IN RESTORING HYDRATION,SKIN pH, AND REDUCING TRANS-EPIDERMAL WATER LOSS(TEWL) IN PATIENTS WITH ATOPIC DERMATITIS

Study Focus

Sponsor & Location

University of Lagos

UNIVERSITY OF LAGOS

Nigeria

Timeline & Enrollment

Phase 2

Aug 01, 2022

Mar 31, 2023

Summary

Background: Atopic dermatitis (AD) is one of the common diseases seen at the dermatology clinic. A major complaint and clinical feature among AD patients is dryness of the skin and this has led to moisturisers being a major part of the treatment of AD. Studies of skin biophysical properties in AD patients reveal decreased hydration and increased trans epidermal water loss (TEWL). A variety of moisturisers are available, and they all claim to be effective at moisturising the skin in patients with AD. Studies documenting their proven efficacy have been carried out in temperate and non-tropical climates. The tropical climate in Nigeria differs considerably, with her hot and humid environment and temperature ranging between 25-40ยฐC. There is a dearth of literature documenting the tolerability and effectiveness of moisturisers in this setting. Topicremยฎ, one of the moisturisers available for use in management of AD is a new product in the Nigerian market. The product is a fluid and non-oily emulsion with a high moisturizing and lipid-replenishing power that instantly penetrates the skin without feeling sticky, thereby conferring 24-hour hydration following daily use. It has been used and validated successfully in other climes; however, it is yet to be clinically tested in Nigeria. The aim of this study, therefore, is to compare the recovery of skin hydration and normalization of TEWL in AD patients by Topicremยฎ, with the use of a validated moisturising lotion.Aim: To assess the efficacy of two moisturisers in restoring hydration, skin pH and Trans Epidermal Water Loss (TEWL) of patients with Atopic Dermatitis.

ICD-10 Classifications

Systemic disorders of connective tissue in diseases classified elsewhere
Systemic disorders of connective tissue in other diseases classified elsewhere
Diseases of the skin and subcutaneous tissue
Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Other disorders of the skin and subcutaneous tissue

Data Source

Pan Africa Clinical Trials Registry

PACTR202209711529835

Non-Device Trial